GlassScriptPhysician profile
Denise M Kimbrough
NPI 1174181911
$697.83
in general payments reported to CMS, 2019-2025
9 companies · $248 in 2025
The $248 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $92.42 · 2024: $357 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $697.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $154.47 | 2025 | Tavneos |
| Travere Therapeutics, INC. | $149.57 | 2024 | |
| Ani Pharmaceuticals, INC. | $104.24 | 2024 | Purified Cortrophin Gel |
| Nxstage Medical, INC. | $98.20 | 2023-2025 | Liberty Select Cycler, Nxstage System One, Pureflow Sl |
| Glaxosmithkline, LLC. | $60.29 | 2023-2024 | Jesduvroq |
| Bayer Healthcare Pharmaceuticals INC. | $50.63 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $31.45 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $26.57 | 2025 | |
| Aurinia Pharma U.S., INC. | $22.41 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Kimbrough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.